Global Recombinant Peptides Market Professional Survey Report 2018

June 2018 | 106 pages | ID: G6DA40EC0BBEN
QYResearch

Abstracts

This report studies the global Recombinant Peptides market status and forecast, categorizes the global Recombinant Peptides market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The global Recombinant Peptides market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

• Sandoz Pharma
• Stada Arzneimittel
• Amgen
• Hospira
• Actavis
• Cipla Ltd.
• Wockhardt Ltd.
• Biocon Ltd.

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

• North America
• Europe
• China
• Japan
• India
• Southeast Asia
• Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Glucagon
• Calcitonin
• Other

By Application, the market can be split into

• Oncology
• Blood Disorders
• Infectious Diseases
• Autoimmune Diseases
• Other

The study objectives of this report are:

• To analyze and study the global Recombinant Peptides capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
• Focuses on the key Recombinant Peptides manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Recombinant Peptides are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Recombinant Peptides Manufacturers
Recombinant Peptides Distributors/Traders/Wholesalers
Recombinant Peptides Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Recombinant Peptides market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Recombinant Peptides Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF RECOMBINANT PEPTIDES

1.1 Definition and Specifications of Recombinant Peptides
  1.1.1 Definition of Recombinant Peptides
  1.1.2 Specifications of Recombinant Peptides
1.2 Classification of Recombinant Peptides
  1.2.1 Glucagon
  1.2.2 Calcitonin
  1.2.3 Other
1.3 Applications of Recombinant Peptides
  1.3.1 Oncology
  1.3.2 Blood Disorders
  1.3.3 Infectious Diseases
  1.3.4 Autoimmune Diseases
  1.3.5 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RECOMBINANT PEPTIDES

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Peptides
2.3 Manufacturing Process Analysis of Recombinant Peptides
2.4 Industry Chain Structure of Recombinant Peptides

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RECOMBINANT PEPTIDES

3.1 Capacity and Commercial Production Date of Global Recombinant Peptides Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Recombinant Peptides Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Recombinant Peptides Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Recombinant Peptides Major Manufacturers in 2017

4 GLOBAL RECOMBINANT PEPTIDES OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Recombinant Peptides Capacity and Growth Rate Analysis
  4.2.2 2017 Recombinant Peptides Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Recombinant Peptides Sales and Growth Rate Analysis
  4.3.2 2017 Recombinant Peptides Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Recombinant Peptides Sales Price
  4.4.2 2017 Recombinant Peptides Sales Price Analysis (Company Segment)

5 RECOMBINANT PEPTIDES REGIONAL MARKET ANALYSIS

5.1 North America Recombinant Peptides Market Analysis
  5.1.1 North America Recombinant Peptides Market Overview
  5.1.2 North America 2013-2018E Recombinant Peptides Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Recombinant Peptides Sales Price Analysis
  5.1.4 North America 2017 Recombinant Peptides Market Share Analysis
5.2 Europe Recombinant Peptides Market Analysis
  5.2.1 Europe Recombinant Peptides Market Overview
  5.2.2 Europe 2013-2018E Recombinant Peptides Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2013-2018E Recombinant Peptides Sales Price Analysis
  5.2.4 Europe 2017 Recombinant Peptides Market Share Analysis
5.3 China Recombinant Peptides Market Analysis
  5.3.1 China Recombinant Peptides Market Overview
  5.3.2 China 2013-2018E Recombinant Peptides Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2013-2018E Recombinant Peptides Sales Price Analysis
  5.3.4 China 2017 Recombinant Peptides Market Share Analysis
5.4 Japan Recombinant Peptides Market Analysis
  5.4.1 Japan Recombinant Peptides Market Overview
  5.4.2 Japan 2013-2018E Recombinant Peptides Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2013-2018E Recombinant Peptides Sales Price Analysis
  5.4.4 Japan 2017 Recombinant Peptides Market Share Analysis
5.5 Southeast Asia Recombinant Peptides Market Analysis
  5.5.1 Southeast Asia Recombinant Peptides Market Overview
  5.5.2 Southeast Asia 2013-2018E Recombinant Peptides Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2013-2018E Recombinant Peptides Sales Price Analysis
  5.5.4 Southeast Asia 2017 Recombinant Peptides Market Share Analysis
5.6 India Recombinant Peptides Market Analysis
  5.6.1 India Recombinant Peptides Market Overview
  5.6.2 India 2013-2018E Recombinant Peptides Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Recombinant Peptides Sales Price Analysis
  5.6.4 India 2017 Recombinant Peptides Market Share Analysis

6 GLOBAL 2013-2018E RECOMBINANT PEPTIDES SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Recombinant Peptides Sales by Type
6.2 Different Types of Recombinant Peptides Product Interview Price Analysis
6.3 Different Types of Recombinant Peptides Product Driving Factors Analysis
  6.3.1 Glucagon Growth Driving Factor Analysis
  6.3.2 Calcitonin Growth Driving Factor Analysis
  6.3.3 Other Growth Driving Factor Analysis

7 GLOBAL 2013-2018E RECOMBINANT PEPTIDES SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Recombinant Peptides Consumption by Application
7.2 Different Application of Recombinant Peptides Product Interview Price Analysis
7.3 Different Application of Recombinant Peptides Product Driving Factors Analysis
  7.3.1 Oncology of Recombinant Peptides Growth Driving Factor Analysis
  7.3.2 Blood Disorders of Recombinant Peptides Growth Driving Factor Analysis
  7.3.3 Infectious Diseases of Recombinant Peptides Growth Driving Factor Analysis
  7.3.4 Autoimmune Diseases of Recombinant Peptides Growth Driving Factor Analysis
  7.3.5 Other of Recombinant Peptides Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RECOMBINANT PEPTIDES

8.1 Sandoz Pharma
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Sandoz Pharma 2017 Recombinant Peptides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Sandoz Pharma 2017 Recombinant Peptides Business Region Distribution Analysis
8.2 Stada Arzneimittel
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Stada Arzneimittel 2017 Recombinant Peptides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Stada Arzneimittel 2017 Recombinant Peptides Business Region Distribution Analysis
8.3 Amgen
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Amgen 2017 Recombinant Peptides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Amgen 2017 Recombinant Peptides Business Region Distribution Analysis
8.4 Hospira
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Hospira 2017 Recombinant Peptides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Hospira 2017 Recombinant Peptides Business Region Distribution Analysis
8.5 Actavis
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Actavis 2017 Recombinant Peptides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Actavis 2017 Recombinant Peptides Business Region Distribution Analysis
8.6 Cipla Ltd.
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Cipla Ltd. 2017 Recombinant Peptides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Cipla Ltd. 2017 Recombinant Peptides Business Region Distribution Analysis
8.7 Wockhardt Ltd.
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Wockhardt Ltd. 2017 Recombinant Peptides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Wockhardt Ltd. 2017 Recombinant Peptides Business Region Distribution Analysis
8.8 Biocon Ltd.
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Biocon Ltd. 2017 Recombinant Peptides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Biocon Ltd. 2017 Recombinant Peptides Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF RECOMBINANT PEPTIDES MARKET

9.1 Global Recombinant Peptides Market Trend Analysis
  9.1.1 Global 2018-2025 Recombinant Peptides Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Recombinant Peptides Sales Price Forecast
9.2 Recombinant Peptides Regional Market Trend
  9.2.1 North America 2018-2025 Recombinant Peptides Consumption Forecast
  9.2.2 Europe 2018-2025 Recombinant Peptides Consumption Forecast
  9.2.3 China 2018-2025 Recombinant Peptides Consumption Forecast
  9.2.4 Japan 2018-2025 Recombinant Peptides Consumption Forecast
  9.2.5 Southeast Asia 2018-2025 Recombinant Peptides Consumption Forecast
  9.2.6 India 2018-2025 Recombinant Peptides Consumption Forecast
9.3 Recombinant Peptides Market Trend (Product Type)
9.4 Recombinant Peptides Market Trend (Application)

10 RECOMBINANT PEPTIDES MARKETING TYPE ANALYSIS

10.1 Recombinant Peptides Regional Marketing Type Analysis
10.2 Recombinant Peptides International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Recombinant Peptides by Region
10.4 Recombinant Peptides Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RECOMBINANT PEPTIDES

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL RECOMBINANT PEPTIDES MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Peptides
Table Product Specifications of Recombinant Peptides
Table Classification of Recombinant Peptides
Figure Global Production Market Share of Recombinant Peptides by Type in 2017
Figure Glucagon Picture
Table Major Manufacturers of Glucagon
Figure Calcitonin Picture
Table Major Manufacturers of Calcitonin
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Recombinant Peptides
Figure Global Consumption Volume Market Share of Recombinant Peptides by Application in 2017
Figure Oncology Examples
Table Major Consumers in Oncology
Figure Blood Disorders Examples
Table Major Consumers in Blood Disorders
Figure Infectious Diseases Examples
Table Major Consumers in Infectious Diseases
Figure Autoimmune Diseases Examples
Table Major Consumers in Autoimmune Diseases
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Recombinant Peptides by Regions
Figure North America Recombinant Peptides Market Size (Million USD) (2013-2025)
Figure Europe Recombinant Peptides Market Size (Million USD) (2013-2025)
Figure China Recombinant Peptides Market Size (Million USD) (2013-2025)
Figure Japan Recombinant Peptides Market Size (Million USD) (2013-2025)
Figure Southeast Asia Recombinant Peptides Market Size (Million USD) (2013-2025)
Figure India Recombinant Peptides Market Size (Million USD) (2013-2025)
Table Recombinant Peptides Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Peptides in 2017
Figure Manufacturing Process Analysis of Recombinant Peptides
Figure Industry Chain Structure of Recombinant Peptides
Table Capacity and Commercial Production Date of Global Recombinant Peptides Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Recombinant Peptides Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Recombinant Peptides Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Recombinant Peptides Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Recombinant Peptides 2013-2018E
Figure Global 2013-2018E Recombinant Peptides Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Recombinant Peptides Market Size (Value) and Growth Rate
Table 2013-2018E Global Recombinant Peptides Capacity and Growth Rate
Table 2017 Global Recombinant Peptides Capacity (K MT) List (Company Segment)
Table 2013-2018E Global Recombinant Peptides Sales (K MT) and Growth Rate
Table 2017 Global Recombinant Peptides Sales (K MT) List (Company Segment)
Table 2013-2018E Global Recombinant Peptides Sales Price (USD/MT)
Table 2017 Global Recombinant Peptides Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Recombinant Peptides 2013-2018E
Figure North America 2013-2018E Recombinant Peptides Sales Price (USD/MT)
Figure North America 2017 Recombinant Peptides Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Recombinant Peptides 2013-2018E
Figure Europe 2013-2018E Recombinant Peptides Sales Price (USD/MT)
Figure Europe 2017 Recombinant Peptides Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Recombinant Peptides 2013-2018E
Figure China 2013-2018E Recombinant Peptides Sales Price (USD/MT)
Figure China 2017 Recombinant Peptides Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Recombinant Peptides 2013-2018E
Figure Japan 2013-2018E Recombinant Peptides Sales Price (USD/MT)
Figure Japan 2017 Recombinant Peptides Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Recombinant Peptides 2013-2018E
Figure Southeast Asia 2013-2018E Recombinant Peptides Sales Price (USD/MT)
Figure Southeast Asia 2017 Recombinant Peptides Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Recombinant Peptides 2013-2018E
Figure India 2013-2018E Recombinant Peptides Sales Price (USD/MT)
Figure India 2017 Recombinant Peptides Sales Market Share
Table Global 2013-2018E Recombinant Peptides Sales (K MT) by Type
Table Different Types Recombinant Peptides Product Interview Price
Table Global 2013-2018E Recombinant Peptides Sales (K MT) by Application
Table Different Application Recombinant Peptides Product Interview Price
Table Sandoz Pharma Information List
Table Product Overview
Table 2017 Sandoz Pharma Recombinant Peptides Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Sandoz Pharma Recombinant Peptides Business Region Distribution
Table Stada Arzneimittel Information List
Table Product Overview
Table 2017 Stada Arzneimittel Recombinant Peptides Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Stada Arzneimittel Recombinant Peptides Business Region Distribution
Table Amgen Information List
Table Product Overview
Table 2017 Amgen Recombinant Peptides Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Amgen Recombinant Peptides Business Region Distribution
Table Hospira Information List
Table Product Overview
Table 2017 Hospira Recombinant Peptides Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Hospira Recombinant Peptides Business Region Distribution
Table Actavis Information List
Table Product Overview
Table 2017 Actavis Recombinant Peptides Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Actavis Recombinant Peptides Business Region Distribution
Table Cipla Ltd. Information List
Table Product Overview
Table 2017 Cipla Ltd. Recombinant Peptides Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Cipla Ltd. Recombinant Peptides Business Region Distribution
Table Wockhardt Ltd. Information List
Table Product Overview
Table 2017 Wockhardt Ltd. Recombinant Peptides Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Wockhardt Ltd. Recombinant Peptides Business Region Distribution
Table Biocon Ltd. Information List
Table Product Overview
Table 2017 Biocon Ltd. Recombinant Peptides Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Biocon Ltd. Recombinant Peptides Business Region Distribution
Figure Global 2018-2025 Recombinant Peptides Market Size (K MT) and Growth Rate Forecast
Figure Global 2018-2025 Recombinant Peptides Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Recombinant Peptides Sales Price (USD/MT) Forecast
Figure North America 2018-2025 Recombinant Peptides Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2018-2025 Recombinant Peptides Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2018-2025 Recombinant Peptides Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Recombinant Peptides Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2018-2025 Recombinant Peptides Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2018-2025 Recombinant Peptides Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Recombinant Peptides by Type 2018-2025
Table Global Consumption Volume (K MT) of Recombinant Peptides by Application 2018-2025
Table Traders or Distributors with Contact Information of Recombinant Peptides by Region